Oncolytics Biotech Inc (ONC)

1.74
-0.02(-1.14%)
  • Volume:
    5,164
  • Bid/Ask:
    1.73/1.75
  • Day's Range:
    1.73 - 1.75

ONC Overview

Prev. Close
1.76
Day's Range
1.73-1.75
Revenue
-
Open
1.74
52 wk Range
1.06-2.92
EPS
-0.437
Volume
5,164
Market Cap
101.72M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
23,844
P/E Ratio
-
Beta
1.73
1-Year Change
-33.84%
Shares Outstanding
58,459,036
Next Earnings Date
Nov 15, 2022
What is your sentiment on Oncolytics Biotech?
or
Market is currently closed. Voting is open during market hours.

Oncolytics Biotech Inc News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

Oncolytics Biotech Inc Analysis

Oncolytics Biotech Inc Company Profile

Oncolytics Biotech Inc Company Profile

Employees
0
Market
Canada
  • Type:Equity
  • Market:Canada
  • ISIN:CA6823108759
  • CUSIP:682310875

Oncolytics Biotech Inc. is a biotechnology company, which is engaged in developing pelareorep, an intravenously delivered immunotherapeutic agent. The Company is focused on the discovery and development of pharmaceutical products for the treatment of cancers. Its lead product, Pelareorep, is a systemically administered immuno-oncology (I-O) viral agent with the potential to treat a variety of cancers. Pelareorep’s anti-tumor activity is based on three modes: selective viral replication in permissive cancer cells, which leads to tumor cell lysis; activation of innate immunity in response to the infection, which results in a cascade of chemokines/cytokines, causing natural killer (NK) cells to be activated and attack cancer cells; and specific adaptive immune response triggered by tumor and viral-associated antigens displayed by antigen presenting cells (APCs), infected tumor cells and dendritic cells to T cells.

Read More

Analyst Price Target

Average7.37 (+323.35% Upside)
High8.5
Low6
Price1.74
No. of Analysts3
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Analysts 12-Month Price Target

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuyBuyBuyBuySell
Technical IndicatorsStrong SellSellBuyStrong SellStrong Sell
SummaryNeutralNeutralBuyNeutralStrong Sell
  • I wonder how much of this increase is due to their positive clinical results compared to stock market vaccine news.?
    0
    • There's more good news coming down the pipe before months end.
      0
      • Fuck that shit the worse stock ever
        2
        • Told ya it'd spike.
          0
      • She's gonna spike up any day here soon.
        2
        • I sold 62 shares got my capital back. Let’s hope this will continue.
          1
          • should hv bought more than 100 shares
            0
            • maybe more buyers than sellers
              0
              • Why are they buying?
                0
              • biopharm, medicals seem to be the safe bet as they are a necessity for future... this one deals with cancers etc
                0
            • Anyone can tell why it’s gaining?
              0